Healthcare provider profile · identity verified

Craig Alan Kaplan, MD

Family Practice · ATLANTA, GA · NPI 1962462556

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	102
Amlodipine Besylate	Amlodipine Besylate	261	84
Rosuvastatin Calcium	Rosuvastatin Calcium	220	67
Omeprazole	Omeprazole	147	61
Lisinopril	Lisinopril	144	47
Levothyroxine Sodium	Levothyroxine Sodium	138	38
Losartan Potassium	Losartan Potassium	128	42
Trazodone Hcl	Trazodone Hcl	111	36
Tamsulosin Hcl	Tamsulosin Hcl	108	38
Pantoprazole Sodium	Pantoprazole Sodium	107	33
Metformin Hcl Er	Metformin Hcl	99	35
Alendronate Sodium	Alendronate Sodium	92	28
Gabapentin	Gabapentin	92	32
Finasteride	Finasteride	83	22
Metformin Hcl	Metformin Hcl	82	25
Albuterol Sulfate Hfa	Albuterol Sulfate	79	27
Metoprolol Succinate	Metoprolol Succinate	68	25
Potassium Chloride	Potassium Chloride	68	24
Allopurinol	Allopurinol	63	18
Glipizide	Glipizide	63	19
Hydrochlorothiazide	Hydrochlorothiazide	62	22
Acyclovir	Acyclovir	52	14
Metoprolol Tartrate	Metoprolol Tartrate	50	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	49	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	15
Simvastatin	Simvastatin	48	13
Furosemide	Furosemide	47	18
Meloxicam	Meloxicam	47	16
Jardiance	Empagliflozin	45	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Pradaxa	Dabigatran Etexilate Mesylate	41	15
Ezetimibe	Ezetimibe	39	13
Carvedilol	Carvedilol	37	14
Mirtazapine	Mirtazapine	36	12
Sertraline Hcl	Sertraline Hcl	36	11
Spironolactone	Spironolactone	34	12
Doxycycline Monohydrate	Doxycycline Monohydrate	33	23
Humulin N	Insulin Nph Human Isophane	33	11
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Ozempic	Semaglutide	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Alvesco	Ciclesonide	29	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	25
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Atenolol	Atenolol	21	suppressed
Testosterone	Testosterone	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Ketoconazole	Ketoconazole	17	11
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Prednisone	Prednisone	14	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Lovastatin	Lovastatin	12	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error